| Literature DB >> 36123894 |
Kuni Akasaka1, Fumi Akasaka1, Tadashi Akasaka1, Kazutake Okada2, Sotaro Sadahiro2,3.
Abstract
Constipation has been reported to be more common in patients with mental disorders than in the general population. However, its relationships with psychiatric diagnosis, medication, age, and sex have not been fully identified. A total of 875 patients from the outpatient department were included in the study. As a retrospective observational study, the psychiatric diagnoses and psychotropic medications were examined based on the medical charts. Fecal conditions, including problems with defecation, abdominal pain, sense of incomplete evacuation, use of laxatives, frequency of defecation, and stool characteristics according to the Bristol Scale, were investigated. The study included 368 males and 507 females, with median ages of 48 and 52 years, respectively. The most common psychiatric diagnoses were depressive disorders (33%), followed by anxiety disorders (19%). Females had significantly higher rates of problems with defecation and laxative use than males (P < .001, P < .0001, respectively). The frequency of laxative use increased significantly with age (P < .0001). The multivariate analyses revealed the close relationship between hypnotics and problems of defecation and that between hypnotics, antipsychotics, and laxative use. In psychiatric outpatients, females had significantly higher rates of problems with defecation and laxative use than males. The use of laxatives significantly increased with age. Problems with defecation were significantly more common in patients taking hypnotics and laxative use was significantly more common in patients taking hypnotics and antipsychotics.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36123894 PMCID: PMC9478243 DOI: 10.1097/MD.0000000000030369
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1.Patients’ psychiatric disorders.
Relationships between clinical factors and problems of defecation, laxative use by univariate analyses.
| Problems of defecation | Laxative users | Laxative nonusers | ||||
|---|---|---|---|---|---|---|
| Present | Absent | |||||
| Sex | ||||||
| Male | 88 (27%) | 243 (73%) | <.001 | 33 (10%) | 295 (90%) | <.0001 |
| Female | 175 (38%) | 286 (62%) | 110 (24%) | 340 (76%) | ||
| Age (yr) | ||||||
| Mean ± SD | 51.1 ± 17.5 | 50.0 ± 16.8 | .8 | 60.7 ± 16.3 | 47.7 ± 16.0 | <.0001 |
| Median | –51 | –48 | –62 | –46 | ||
| Psychiatric diagnoses | ||||||
| Depressive disorders | 100 (37%) | 169 (63%) | 0.63 | 56 (21%) | 213 (79%) | .045 |
| Anxiety disorders | 43 (28%) | 110 (72%) | 23 (15%) | 126 (85%) | ||
| Trauma- and stress-related disorders | 27 (29%) | 66 (71%) | 9 (10%) | 85 (90%) | ||
| Neurodevelopmental disorders | 32 (39%) | 51 (61%) | 14 (17%) | 67 (83%) | ||
| Schizophrenia and other psychotic disorders | 15 (29%) | 36 (7%) | 11 (24%) | 35 (76%) | ||
| Somatic symptoms and related disorders | 14 (35%) | 26 (65%) | 12 (31%) | 27 (69%) | ||
| Sleep–wake disorders | 8 (30%) | 19 (70%) | 8 (30%) | 19 (70%) | ||
| Bipolar and related disorders | 8 (31%) | 18 (69%) | 2 (8%) | 23 (92%) | ||
| Others | 12 (34%) | 23 (66%) | 6 (18%) | 28 (82%) | ||
| Psychotropic drugs | ||||||
| Hypnotics | ||||||
| Yes | 139 (37%) | 233(63%) | 0.024 | 89 (24%) | 275 (76%) | <.0001 |
| No | 123 (30%) | 293(70%) | 53 (13%) | 358 (87%) | ||
| Antipsychotics | ||||||
| Yes | 53 (37%) | 89 (63%) | 0.25 | 35 (26%) | 101 (74%) | .014 |
| No | 209 (32%) | 437 (68%) | 107 (17%) | 532 (83%) | ||
| Antianxiety drugs | ||||||
| Yes | 149 (34%) | 287 (66%) | 0.54 | 89 (21%) | 345 (79%) | .08 |
| No | 113 (32%) | 239 (68%) | 53 (16%) | 288 (84%) | ||
| Antidepressants | ||||||
| Yes | 159 (34%) | 314 (66%) | 0.79 | 92 (20%) | 378 (79%) | .26 |
| No | 103 (33%) | 212 (67%) | 50 (16%) | 255 (84%) | ||
| Anticholinergics | ||||||
| Yes | 7 (32%) | 15 (68%) | 0.89 | 6 (27%) | 16 (73%) | .27 |
| No | 255 (33%) | 511 (67%) | 136 (18%) | 616 (82%) | ||
| Antiepileptic drugs | ||||||
| Yes | 22 (29%) | 53(71%) | 0.45 | 10 (17%) | 58 (83%) | .41 |
| No | 240 (34%) | 473(66%) | 132 (23%) | 575 (77%) | ||
| Number of psychotropic drugs | ||||||
| ≤2 | 129 (30%) | 297 (70%) | 0.068 | 56 (14%) | 360 (86%) | .0006 |
| ≥3 | 132 (37%) | 228 (63%) | 82 (23%) | 271 (77%) | ||
| GAF | ||||||
| ≤30 | 15 (38%) | 25 (62%) | 0.1 | 11 (31%) | 25 (69%) | .11 |
| 31–60 | 150 (36%) | 266 (64%) | 69 (17%) | 344 (83%) | ||
| 60< | 82 (29%) | 205 (71%) | 54 (19%) | 229 (81%) | ||
GAF = Global Assessment of Functioning (American Psychiatric Association, 1994), SD = standard deviation.
Figure 2.Frequency of laxative use by age group. Solid column: laxative users. Hollow column: laxative nonusers. The frequency increases with age (P < .0001). Patients in their teens and 90s were excluded due to small sample size.
The relationships between clinical characteristics, psychotropic medications, problems with defecation, and laxative use by multivariate analyses.
| Problems of defecation | Laxative use | |||||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | Odds ratio | 95% CI | |||
| Sex | ||||||
| Male | 1.00 | Reference | 1.00 | Reference | ||
| Female | 1.70 | 1.25–2.32 | <.001 | 2.70 | 1.72–4.22 | <.001 |
| Age (yr) | ||||||
| <53 | 1.00 | Reference | ||||
| >=53 | 3.95 | 2.54–6.12 | <.001 | |||
| Psychiatric diagnoses | ||||||
| Depressive disorders | 4.47 | 0.92–21.81 | .064 | |||
| Anxiety disorders | 4.68 | 0.92–23.92 | .064 | |||
| Trauma- and stress-related disorders | 3.18 | 0.57–17.69 | .186 | |||
| Neurodevelopmental disorders | 6.84 | 1.29–36.27 | .024 | |||
| Schizophrenia and other psychotic disorders | 2.79 | 0.53–14.72 | .227 | |||
| Somatic symptoms and related disorders | 7.67 | 1.36–43.46 | .021 | |||
| Sleep-wake disorders | 5.74 | 0.94–35.15 | .059 | |||
| Bipolar and related disorders | 1.00 | Reference | ||||
| Others | 3.58 | 0.59–21.58 | .164 | |||
| Psychotropic drugs | ||||||
| Hypnotics | ||||||
| Yes | 1.42 | 1.05–1.92 | .021 | 1.67 | 1.03–2.71 | .038 |
| No | 1.00 | Reference | 1.00 | Reference | ||
| Antipsychotics | ||||||
| Yes | 2.27 | 1.25–4.14 | .007 | |||
| No | 1.00 | Reference | ||||
| Number of psychotropic drugs | ||||||
| ≦2 | 1.00 | Reference | .573 | |||
| >=3 | 1.15 | 0.71–1.88 | ||||
CI = confidence interval.